-

The federal departments have officially revoked previous leniency regarding transparency in coverage rules, signaling a stricter enforcement of machine-readable file requirements for health plans. This move ends two key non-enforcement policies: the delayed requirement for health plans to publish drug pricing data and the safe harbor allowing flexibility for complex reimbursement arrangements. By rescinding these accommodations, the government aims to ensure that the mandated data transparency is fully realized without the previous delays or exceptions that hindered complete compliance. The termination of the deferral on drug pricing files stems from the conclusion that these disclosures do not overlap with other existing reporting obligations. Consequently, plan sponsors must now prioritize gathering and posting this data, with the expectation that future technical guidance will provide a reasonable implementation timeline. This shift emphasizes the necessity for employers to collaborate closely with service providers to build robust data collection processes, ensuring they can meet the new standards promptly without facing immediate penalties. For in-network rates, the immediate removal of the safe harbor for non-standard reimbursement arrangements requires swift action from plan sponsors. Without a stated implementation grace period, entities relying on this exception must immediately assess their compliance status and adjust their reporting methods. This development is highly relevant to open data initiatives as it forces the healthcare sector to release granular, standardized pricing information to the public, thereby enhancing market transparency and consumer awareness regarding actual healthcare costs.

Source:
Published on 2023-10-06

Open Data

Related news